Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionArgent Trust Co
Latest Disclosed Ownership38,288 shares
Latest Disclosed Value $ 5,848,536
Argent Trust Co reports 5.07% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Argent Trust Co filed a 13F-HR form disclosing ownership of 38,288 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $5,848,492 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 40,333 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -5.07% during the quarter. The current value of the position is $5,500,454 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 38,288 -2,045 -5.07 5,849 5.18 0.0773
2026-02-10 2025-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 40,333 291 0.73 5,561 8.30 0.1907
2025-11-12 2025-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 40,042 1,147 2.95 5,135 9.09 0.1820
2025-08-12 2025-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 38,895 2,038 5.53 4,707 14.56 0.1776
2025-05-09 2025-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 36,857 1,234 3.46 4,109 18.52 0.1686
2025-02-13 2024-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 35,623 608 1.74 3,466 -13.93 0.1413
2024-11-13 2024-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 35,015 -560 -1.57 4,027 6.34 0.1667
2024-08-12 2024-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 35,575 1,574 4.63 3,787 15.18 0.1667
2024-05-10 2024-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,001 -417 -1.21 3,289 -5.38 0.1479
2024-02-09 2023-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,418 -351 -1.01 3,475 -1.86 0.1729
2023-11-08 2023-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,769 -152 -0.44 3,542 0.51 0.1941
2023-08-11 2023-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,921 -840 -2.35 3,524 7.08 0.1909
2023-05-12 2023-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 35,761 1,323 3.84 3,290 5.31 0.2084
2023-02-10 2022-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,438 -2,863 -7.68 3,124 10.19 0.2066
2022-11-10 2022-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 37,301 857 2.35 2,835 -7.95 0.2052
2022-08-11 2022-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 36,444 -156 -0.43 3,080 -4.11 0.2113
2022-05-11 2022-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 36,600 -253 -0.69 3,212 -0.37 0.1958
2022-02-09 2021-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 36,853 -1,320 -3.46 3,224 3.27 0.1887
2021-11-09 2021-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 38,173 169 0.44 3,122 -9.98 0.2006
2021-08-09 2021-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 38,004 339 0.90 3,468 7.70 0.2276
2021-05-12 2021-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 37,665 906 2.46 3,220 -7.23 0.2263
2021-02-11 2020-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 36,759 -3,139 -7.87 3,471 0.06 0.2682
2020-11-13 2020-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 39,898 1,661 4.34 3,469 3.89 0.3056
2020-08-04 2020-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 38,237 3,709 10.74 3,339 17.32 0.3129
2020-05-11 2020-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,528 -733 -2.08 2,846 -14.76 0.3198
2020-02-11 2019-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 35,261 381 1.09 3,339 10.16 0.2970
2019-11-12 2019-09-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 34,880 4,321 14.14 3,031 8.60 0.2922
2019-08-13 2019-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 30,559 248 0.82 2,791 -4.22 0.2830
2019-05-15 2019-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 30,311 1,618 5.64 2,914 18.36 0.3051
2019-02-06 2018-12-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 28,693 15,057 110.42 2,462 109.35 0.2889
2018-11-14 2018-09-30 13F NOVARTIS AG ADR COM 66987V109 13,636 1,000 7.91 1,176 23.27 0.1356
2019-04-15 2018-06-30 13F/A-1 NOVARTIS AG ADR COM 66987V109 12,636 -273 -2.11 954 -8.53 0.1163
2018-08-15 2018-06-30 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 26,141 13,232 1,975
2018-05-15 2018-03-31 13F NOVARTIS AG ADR FOREIGN STOCK 66987V109 12,909 4,168 47.68 1,043 42.10 0.2991
2018-02-12 2017-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 8,741 -188 -2.11 734 -4.30 0.2872
2017-11-13 2017-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 8,929 100 1.13 767 4.07 0.3025
2017-08-09 2017-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 8,829 832 10.40 737 24.07 0.3042
2017-05-08 2017-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 7,997 1,452 22.18 594 24.79 0.2455
2017-02-14 2016-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 6,545 -2,536 -27.93 476 -33.61 0.2106
2016-11-09 2016-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,081 1,839 25.39 717 20.10 0.3042
2016-08-04 2016-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 7,242 1,899 35.54 597 54.26 0.2627
2016-05-10 2016-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 5,343 5,343 387 0.1876
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.